Synthesis, crystal structure, Hirshfeld Surface analysis, and DFT studies of 16-ferrocenylidene-17β-estra-1,3,5-triene-3,17-diol: Towards the application of ferrocene-hormone conjugates to target hormone dependent breast cancer